These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 16540315)

  • 1. Synthesis and evaluation of 4-substituted benzylamine derivatives as beta-tryptase inhibitors.
    Miyazaki Y; Kato Y; Manabe T; Shimada H; Mizuno M; Egusa T; Ohkouchi M; Shiromizu I; Matsusue T; Yamamoto I
    Bioorg Med Chem Lett; 2006 Jun; 16(11):2986-90. PubMed ID: 16540315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combinatorial approaches towards the discovery of new tryptase inhibitors.
    del Fresno M; Fernández-Forner D; Miralpeix M; Segarra V; Ryder H; Royo M; Albericio F
    Bioorg Med Chem Lett; 2005 Mar; 15(6):1659-64. PubMed ID: 15745817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of potent and highly selective nonguanidine azetidinone inhibitors of human tryptase.
    Bisacchi GS; Slusarchyk WA; Bolton SA; Hartl KS; Jacobs G; Mathur A; Meng W; Ogletree ML; Pi Z; Sutton JC; Treuner U; Zahler R; Zhao G; Seiler SM
    Bioorg Med Chem Lett; 2004 May; 14(9):2227-31. PubMed ID: 15081014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel pyrazinone inhibitors of mast cell tryptase: synthesis and SAR evaluation.
    Hopkins C; Neuenschwander K; Scotese A; Jackson S; Nieduzak T; Pauls H; Liang G; Sides K; Cramer D; Cairns J; Maignan S; Mathieu M
    Bioorg Med Chem Lett; 2004 Oct; 14(19):4819-23. PubMed ID: 15341931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1,2-Benzisothiazol-3-one 1,1-dioxide inhibitors of human mast cell tryptase.
    Combrink KD; Gülgeze HB; Meanwell NA; Pearce BC; Zulan P; Bisacchi GS; Roberts DG; Stanley P; Seiler SM
    J Med Chem; 1998 Nov; 41(24):4854-60. PubMed ID: 9822554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potent, small-molecule inhibitors of human mast cell tryptase. Antiasthmatic action of a dipeptide-based transition-state analogue containing a benzothiazole ketone.
    Costanzo MJ; Yabut SC; Almond HR; Andrade-Gordon P; Corcoran TW; De Garavilla L; Kauffman JA; Abraham WM; Recacha R; Chattopadhyay D; Maryanoff BE
    J Med Chem; 2003 Aug; 46(18):3865-76. PubMed ID: 12930148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis and biological activity of a targeted library of potential tryptase inhibitors.
    García M; del Rio X; Silvestre S; Rubiralta M; Lozoya E; Segarra V; Fernández D; Miralpeix M; Aparici M; Diez A
    Org Biomol Chem; 2004 Jun; 2(11):1633-42. PubMed ID: 15162216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solid-phase synthesis and SAR of 4-carboxy-2-azetidinone mechanism-based tryptase inhibitors.
    Sutton JC; Bolton SA; Davis ME; Hartl KS; Jacobson B; Mathur A; Ogletree ML; Slusarchyk WA; Zahler R; Seiler SM; Bisacchi GS
    Bioorg Med Chem Lett; 2004 May; 14(9):2233-9. PubMed ID: 15081015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitors of serine proteases as potential therapeutic agents: the road from thrombin to tryptase to cathepsin G.
    Maryanoff BE
    J Med Chem; 2004 Feb; 47(4):769-87. PubMed ID: 14761180
    [No Abstract]   [Full Text] [Related]  

  • 10. Synthesis of potent and selective 2-azepanone inhibitors of human tryptase.
    Zhao G; Bolton SA; Kwon C; Hartl KS; Seiler SM; Slusarchyk WA; Sutton JC; Bisacchi GS
    Bioorg Med Chem Lett; 2004 Jan; 14(2):309-12. PubMed ID: 14698147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pyrrole carboxamidine tryptase inhibitors from Leptonychia pubescens.
    Yang LK; Ng SP; Flotow H; Yoganathan K; Daramola BO; Soejarto DD; Buss AD; Butler MS
    Planta Med; 2005 Nov; 71(11):1071-2. PubMed ID: 16320213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient synthesis of an enantiopure beta-lactam as an advanced precursor of thrombin and tryptase inhibitors.
    Annunziata R; Benaglia M; Cinquini M; Cozzi F; Maggioni F; Puglisi A
    J Org Chem; 2003 Apr; 68(7):2952-5. PubMed ID: 12662075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of human beta-tryptase by Bowman-Birk inhibitor derived peptides: creation of a new tri-functional inhibitor.
    Scarpi D; McBride JD; Leatherbarrow RJ
    Bioorg Med Chem; 2004 Dec; 12(23):6045-52. PubMed ID: 15519150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of potent and highly selective inhibitors of human tryptase.
    Slusarchyk WA; Bolton SA; Hartl KS; Huang MH; Jacobs G; Meng W; Ogletree ML; Pi Z; Schumacher WA; Seiler SM; Sutton JC; Treuner U; Zahler R; Zhao G; Bisacchi GS
    Bioorg Med Chem Lett; 2002 Nov; 12(21):3235-8. PubMed ID: 12372541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1,2,5-Thiadiazolidin-3-one 1,1-dioxide-based heterocyclic sulfides are potent inhibitors of human tryptase.
    Wong T; Groutas CS; Mohan S; Lai Z; Alliston KR; Vu N; Schechter NM; Groutas WC
    Arch Biochem Biophys; 2005 Apr; 436(1):1-7. PubMed ID: 15752703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design of potent selective zinc-mediated serine protease inhibitors.
    Katz BA; Clark JM; Finer-Moore JS; Jenkins TE; Johnson CR; Ross MJ; Luong C; Moore WR; Stroud RM
    Nature; 1998 Feb; 391(6667):608-12. PubMed ID: 9468142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increase of anti-metastatic efficacy by selectivity- but not affinity-optimization of synthetic serine protease inhibitors.
    Banke IJ; Arlt MJ; Pennington C; Kopitz C; Steinmetzer T; Schweinitz A; Gansbacher B; Quigley JP; Edwards DR; Stürzebecher J; Krüger A
    Biol Chem; 2003; 384(10-11):1515-25. PubMed ID: 14669995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dibasic inhibitors of human mast cell tryptase. Part 2: structure-activity relationships and requirements for potent activity.
    Rice KD; Wang VR; Gangloff AR; Kuo EY; Dener JM; Newcomb WS; Young WB; Putnam D; Cregar L; Wong M; Simpson PJ
    Bioorg Med Chem Lett; 2000 Oct; 10(20):2361-6. PubMed ID: 11055356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recruiting Zn2+ to mediate potent, specific inhibition of serine proteases.
    Katz BA; Luong C
    J Mol Biol; 1999 Sep; 292(3):669-84. PubMed ID: 10497030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. beta-Lactam derivatives as inhibitors of human cytomegalovirus protease.
    Yoakim C; Ogilvie WW; Cameron DR; Chabot C; Guse I; Haché B; Naud J; O'Meara JA; Plante R; Déziel R
    J Med Chem; 1998 Jul; 41(15):2882-91. PubMed ID: 9667976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.